Premium
Premium statistics

Industry-specific and extensively researched technical data (partially from exclusive partnerships).

A paid subscription is required for full access.

Manufacture of global synthetic opioids by type 2013-2017

Manufacture of synthetic opioids worldwide from 2013 to 2017, by type (in kilograms)

by Matej Mikulic, last edited Jul 11, 2019
Manufacture of global synthetic opioids by type 2013-2017 This statistic displays the manufacture of synthetic opioids globally from 2013 to 2017, by type. In 2013, there were 14.1 thousand kilograms of diphenoxylate manufactured worldwide. This consumption of this drug has continued to increase over the last two decades, where India was one of the main manufacturers.
Show more

Manufacture of synthetic opioids worldwide from 2013 to 2017, by type (in kilograms)

Statista Accounts: Access All Statistics. Starting from $588 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account!

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$49 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.
Leading companies trust Statista:
paypalgoogleadobepgsamsungtelekom
Statista is a great source of knowledge, and pretty helpful to manage the daily work.
Christof Baron

Christof Baron
CEO, MindShare Germany

Statistics on "Drug use in Denmark"
  • Overview
The most important statistics
  • Cannabis
  • Tobacco
  • Amphetamines, cocoaine, ecstasy
  • Drug treatments
  • Drug-related deaths
  • Drug-related crime
Discover Statista
Need help with using Statista for your research? Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Learn more about how Statista can support your business.
Do you have any questions about our business solutions?

We provide you with detailed information about our Corporate Account.